WallStSmart

EMCOR Group Inc (EME)vsUnitedHealth Group Incorporated (UNH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

UnitedHealth Group Incorporated generates 2434% more annual revenue ($449.71B vs $17.75B). EME leads profitability with a 7.5% profit margin vs 2.7%. EME appears more attractively valued with a PEG of 1.08. EME earns a higher WallStSmart Score of 64/100 (C+).

EME

Buy

64

out of 100

Grade: C+

Growth: 8.7Profit: 7.0Value: 5.0Quality: 6.3
Piotroski: 5/9Altman Z: 4.41

UNH

Buy

54

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 7.3Quality: 4.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EME.

UNHUndervalued (+43.1%)

Margin of Safety

+43.1%

Fair Value

$639.67

Current Price

$367.28

$272.39 discount

UndervaluedFair: $639.67Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EME4 strengths · Avg: 9.0/10
Return on EquityProfitability
39.2%10/10

Every $100 of equity generates 39 in profit

Altman Z-ScoreHealth
4.4110/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
19.7%8/10

19.7% revenue growth

EPS GrowthGrowth
30.0%8/10

Earnings expanding 30.0% YoY

UNH2 strengths · Avg: 9.0/10
Market CapQuality
$336.72B10/10

Mega-cap, among the largest globally

Free Cash FlowQuality
$8.15B8/10

Generating 8.1B in free cash flow

Areas to Watch

EME4 concerns · Avg: 3.3/10
P/E RatioValuation
30.4x4/10

Premium valuation, high expectations priced in

Price/BookValuation
11.4x4/10

Trading at 11.4x book value

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Free Cash FlowQuality
$-28.15M2/10

Negative free cash flow — burning cash

UNH4 concerns · Avg: 3.8/10
P/E RatioValuation
27.9x4/10

Moderate valuation

Revenue GrowthGrowth
2.0%4/10

2.0% revenue growth

EPS GrowthGrowth
0.7%4/10

0.7% earnings growth

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : EME

The strongest argument for EME centers on Return on Equity, Altman Z-Score, Revenue Growth. Revenue growth of 19.7% demonstrates continued momentum. PEG of 1.08 suggests the stock is reasonably priced for its growth.

Bull Case : UNH

The strongest argument for UNH centers on Market Cap, Free Cash Flow. PEG of 1.28 suggests the stock is reasonably priced for its growth.

Bear Case : EME

The primary concerns for EME are P/E Ratio, Price/Book, Profit Margin.

Bear Case : UNH

The primary concerns for UNH are P/E Ratio, Revenue Growth, EPS Growth. Thin 2.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

EME profiles as a growth stock while UNH is a value play — different risk/reward profiles.

EME carries more volatility with a beta of 1.11 — expect wider price swings.

EME is growing revenue faster at 19.7% — sustainability is the question.

UNH generates stronger free cash flow (8.1B), providing more financial flexibility.

Bottom Line

EME scores higher overall (64/100 vs 54/100) and 19.7% revenue growth. UNH offers better value entry with a 43.1% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

EMCOR Group Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

EMCOR Group, Inc. provides electrical and mechanical installation and construction services in the United States. The company is headquartered in Norwalk, Connecticut.

UnitedHealth Group Incorporated

HEALTHCARE · HEALTHCARE PLANS · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services. In 2020, it was the second-largest healthcare company (behind CVS Health) by revenue with $257.1 billion, and the largest insurance company by net premiums. UnitedHealthcare revenues comprise 80% of the Group's overall revenue.

Visit Website →

Want to dig deeper into these stocks?